Johnson and Johnson Innovative Medicine, United States
Disclosure information not submitted.
Characterizing perinatal treatment patterns and outcomes in rheumatologic disease: A retrospective cohort study in a US health insurance claims database
Tuesday, August 27, 20241:00 PM – 1:15 PM CEST